ArticleBreast cancer research and treatment2026

Sacituzumab-induced severe or febrile neutropenia and G-CSF utilization and cost for advanced HER2-negative breast cancer: a single-center retrospective analysis.

Grace Tam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.